GlassScriptPhysician profile
Marci Loree Lowe
NPI 1295995827
$4,153.22
in general payments reported to CMS, 2019-2025
31 companies · $1,660 in 2025
The $1,660 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $468 · 2023: $950 · 2024: $911 · 2025: $1,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,476 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,476.34 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $508.10 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $498.34 | 2022-2024 | Xtampza |
| Medtronic, INC. | $496.13 | 2023-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Genzyme Corporation | $473.44 | 2023-2025 | |
| Corcept Therapeutics | $325.11 | 2025 | Korlym |
| Amgen INC. | $317.39 | 2024-2025 | Krystexxa, Evenity, Tavneos |
| Astrazeneca Pharmaceuticals LP | $205.20 | 2025 | Saphnelo |
| Ucb, INC. | $179.94 | 2025 | Bimzelx |
| Bayer Healthcare Pharmaceuticals INC. | $117.83 | 2022 | |
| Ibsa Pharma INC. | $105.12 | 2021-2023 | Tirosint, Licart |
| Jazz Pharmaceuticals INC. | $100.04 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.45 | 2023 | Relistor |
| Novartis Pharmaceuticals Corporation | $82.67 | 2025 | |
| Sanofi-Aventis U.S. LLC | $81.88 | 2024 | |
| Scilex Pharmaceuticals INC. | $74.77 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $70.64 | 2025 | Tremfya, Simponi Aria |
| Azurity Pharmaceuticals, INC. | $70.20 | 2023 | Horizant |
| Hikma Pharmaceuticals USA | $60.91 | 2022 | |
| Arbor Pharmaceuticals, INC. | $40.38 | 2021-2022 | |
| Valinor Pharma, LLC | $37.29 | 2023 | Movantik |
| Boston Scientific Corporation | $32.35 | 2023 | Wavewriter Alpha Prime 16 |
| Almatica Pharma LLC | $26.68 | 2021 | |
| Ani Pharmaceuticals, INC. | $23.13 | 2025 | Purified Cortrophin Gel |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.67 | 2025 | Cabtreo, Jublia, Siliq |
| Spinal Simplicity, LLC | $19.69 | 2024 | Ha Minuteman G3-R |
| Alexion Pharmaceuticals, INC. | $18.43 | 2025 | Strensiq |
| Horizon Therapeutics Plc | $17.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.36 | 2024 | Exparel |
| Redhill Biopharma INC. | $17.00 | 2021 | |
| Protega Pharmaceutials INC | $14.88 | 2023 | Roxybond |
| Abbott Laboratories | $14.56 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marci Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.